Lonza Group (OTCMKTS:LZAGY) Stock Passes Below 50 Day Moving Average – What’s Next?

Shares of Lonza Group Ag (OTCMKTS:LZAGY) passed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $65.99 and traded as low as $62.68. Lonza Group shares last traded at $63.85, with a volume of 63,905 shares.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on LZAGY shares. Royal Bank Of Canada raised shares of Lonza Group from a “hold” rating to a “moderate buy” rating in a research report on Wednesday, February 11th. Zacks Research lowered shares of Lonza Group from a “hold” rating to a “strong sell” rating in a research report on Wednesday, February 4th. One equities research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold”.

Lonza Group Stock Performance

The stock has a 50 day moving average price of $65.99 and a two-hundred day moving average price of $67.27. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.77 and a current ratio of 2.24.

Lonza Group Company Profile

Lonza Group is a Swiss multinational life sciences company that provides products and services to the pharmaceutical, biotech and specialty ingredients markets. Headquartered in Switzerland, the company operates globally with manufacturing and research facilities across Europe, North America and Asia, serving customers involved in drug discovery, development and commercial production. Lonza’s client base ranges from large pharmaceutical firms to emerging biotech companies and manufacturers of consumer health and specialty chemical products.

The company’s core activities center on contract development and manufacturing (CDMO) for small molecules and biologics, including process development, clinical and commercial-scale manufacturing, and fill–finish services.